Radioimmunoscintigraphy for Postprostatectomy Radiotherapy: Analysis of Toxicity and Biochemical Control
Ashesh B. Jani, MD, MSEE1,
Michael J. Blend, PhD, DO2,
Russell Hamilton, PhD3,
Charles Brendler, MD4,
Charles Pelizzari, PhD1,
Lani Krauz, RN1,
Bipin Sapra, MTech1,
Srinivasan Vijayakumar, MD5,
Azhar Awan, MD1 and
Ralph R. Weichselbaum, MD1
1 Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois
2 Section of Nuclear Medicine, Department of Radiology, University of Illinois, Chicago, Illinois
3 Department of Radiation Oncology, University of Arizona, Tucson, Arizona
4 Section of Urology, Department of Surgery, University of Chicago, Chicago, Illinois
5 Department of Radiation Oncology, University of California, Davis, California

View larger version (14K):
[in a new window]
|
FIGURE 1. Kaplan-Meier BFFS curves: group A vs. group B (A); subgroup B1 vs. subgroup B2 (B); group A vs. subgroup B1 (C); group A vs. subgroup B2 (D).
|
|
Copyright © 2004 by the Society of Nuclear Medicine.